Overview

Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section

Status:
Terminated
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The study evaluate the quality of epidural anaesthesia and the safety of Chloroprocaine HCl 3% compared with Ropivacaine HCl 0.75% in patients with an epidural catheter in situ undergoing unplanned Caesarean section.
Phase:
Phase 3
Details
Lead Sponsor:
Sintetica SA
Collaborators:
Aml Research
Cross Research S.A.
Treatments:
Anesthetics
Chloroprocaine
Pharmaceutical Solutions
Procaine
Ropivacaine